Horizon Pharma PLC | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.26 |
Market Cap |
$4.5 B |
Shares Outstanding |
184.88 M |
Public Float |
167.33 M |
Address |
Connaught House Dublin Dublin 4 Ireland |
Employees | - |
Website | http://www.horizontherapeutics.com |
Updated | 07/08/2019 |
Horizon Pharma Plc engages in the research, development and market of pharmaceutical products. The medicines intend to treat arthritis, inflammation and orphan diseases. It distributes its products under the brands such as Actimmune, Buphenyl, Duexis, Krystexxa, Migergot, Pennsaid, Ravicti, Rayos and Vimovo. |